Merck Animal Health, known as MSD Animal Health outside of the US and Canada, a division of Merck & Co. Inc. announced an 895 million expansion of Merck Animal Health’s manufacturing facility in De Soto, KS.

The $895 million capital expansion will be constructed on an existing Merck-owned property that is the site of its biologics facility in De Soto, Kansas. It includes an $860 million investment in the site’s existing manufacturing facility and a further $35 million investment in its research and development laboratories. 

The 200,000-sq.-ft manufacturing facility project will expand filling and freeze dryer capacity for large molecule vaccines and biologic products for Merck Animal Health. As a Center of Excellence, it will play a pivotal role in the manufacturing of Merck Animal Health’s products and will complement Merck Animal Health’s extensive U.S. and international network of animal health product manufacturing plants. 

Site preparation and facility design will start immediately, creating 2,500 construction jobs. Commercial manufacturing is expected to begin in 2030, creating more than 200 full-time roles.

Merck Animal Health’s significant investment in its research and development laboratories will enhance its research capabilities, focusing on advancing Merck Animal Health’s global drug discovery and development initiatives. The investment will continue to drive Merck Animal Health’s innovative research and development of novel parasiticides and therapeutics, reinforcing the company’s dedication to improving animal health and welfare worldwide.

Related:Kaeser Compressors Breaks Ground on US Expansion

“Our De Soto, Kansas manufacturing facility is strategically located in the heart of the Animal Health Corridor. This region is renowned for its concentration of animal health companies, fostering an unparalleled ecosystem for innovation, collaboration and industry leadership,” said Richard DeLuca, president, Merck Animal Health. “This investment in our site is designed to increase Merck Animal Health’s ability to meet the growing customer demand for its portfolio of animal biologics products and ensure the company remains at the forefront of innovation in the animal health sector. This initiative also reflects our dedication to advancing animal health and our on-going investment in the communities where we operate.”

Merck Animal Health is partnering with the state of Kansas on expansion of the existing manufacturing facility. The investment demonstrates Merck Animal Health’s commitment to the US market, in which the company has significantly invested to deliver innovative health solutions that advance the prevention and treatment of animal diseases. This expansion is one of the largest economic development projects in Kansas’ recent history and the largest for Merck Animal Health.

Related:Chobani Breaks Ground on $1.2B Natural Foods Plant